R01HL169157
Project Grant
Overview
Grant Description
Mechanisms of Uterine Artery Hemodynamics Adaptation to Pregnancy and Gestational Hypoxia - Project Summary
Pregnancy is associated with a striking increase of uterine blood flow that is essential for normal fetal development as well as for cardiovascular well-being of the mother. Hypoxia during pregnancy has profound adverse effects on uterine artery hemodynamics adaptation, increasing incidence of pregnancy complications including preeclampsia and fetal intrauterine growth restriction.
Previous studies in an animal model of pregnant sheep acclimatized to high altitude hypoxia demonstrated that pregnant ewes were similar to pregnant women in that they both showed an increase in uterine vascular resistance and elevation in maternal systemic blood pressure in response to gestational hypoxia. Yet, much remains unknown of the mechanisms underlying maternal cardiovascular maladaptation to chronic hypoxia during pregnancy.
Our preliminary study in sheep suggests a highly novel mechanism of a monomeric G protein, RAD, in inhibition of L-type CAV1.2 calcium channel currents in the uterine artery. The L-type CAV1.2 calcium channel, as the major pathway of Ca2+ influx, is essential for vascular smooth muscle contractions and plays a central role in regulating organ blood flow and arterial pressure.
We identify that both ovine and human RAD gene promoters have multiple estrogen response elements (EREs), suggesting a robust mechanism of sex steroid hormones in the regulation of RAD gene expression in the uterine artery. In addition, the approach of RNA-seq analysis revealed a downregulation of RAD gene expression in uterine arteries of pregnant ewes acclimatized to high altitude hypoxia.
Of importance, we demonstrated that chronic hypoxia during gestation abrogated pregnancy-induced upregulation of RAD protein expression and increased CAV1.2 channel currents in ovine uterine arteries. These exciting findings and many highly novel leads provide a strong scientific premise for us to move the field forward significantly by launching a new focus of research aimed at understanding the molecular and epigenetic mechanisms of RAD in regulating CAV1.2 channel currents and phenotypic programming of uterine vascular adaptation to pregnancy and gestational hypoxia.
The proposed study will be conducted in a unique animal model of pregnant sheep exposed to high altitude (3801 m/12,470 ft) hypoxia during gestation. The overall hypothesis of the proposed study is that RAD is a novel regulatory mechanism and plays an essential role in the regulation of L-type CAV1.2 calcium channel currents and uterine vascular adaptation to pregnancy and gestational hypoxia.
The proposed study has the strong scientific premise with a novel conceptual framework and mechanistic approach. It will provide new insights into fundamental mechanisms in uterine vascular adaptation to pregnancy and will have a major impact on our understanding of pathophysiologic mechanisms underlying pregnancy complications including preeclampsia caused by gestational hypoxia.
Of importance, the similarity in uterine artery hemodynamics and maternal blood pressure responses to gestational hypoxia between pregnant ewes and pregnant women, as well as likely common mechanisms of RAD gene regulation by sex steroid hormones, will provide much-needed translational relevance of the proposed study in the understanding of maternal cardiovascular complications in response to hypoxia during pregnancy.
Pregnancy is associated with a striking increase of uterine blood flow that is essential for normal fetal development as well as for cardiovascular well-being of the mother. Hypoxia during pregnancy has profound adverse effects on uterine artery hemodynamics adaptation, increasing incidence of pregnancy complications including preeclampsia and fetal intrauterine growth restriction.
Previous studies in an animal model of pregnant sheep acclimatized to high altitude hypoxia demonstrated that pregnant ewes were similar to pregnant women in that they both showed an increase in uterine vascular resistance and elevation in maternal systemic blood pressure in response to gestational hypoxia. Yet, much remains unknown of the mechanisms underlying maternal cardiovascular maladaptation to chronic hypoxia during pregnancy.
Our preliminary study in sheep suggests a highly novel mechanism of a monomeric G protein, RAD, in inhibition of L-type CAV1.2 calcium channel currents in the uterine artery. The L-type CAV1.2 calcium channel, as the major pathway of Ca2+ influx, is essential for vascular smooth muscle contractions and plays a central role in regulating organ blood flow and arterial pressure.
We identify that both ovine and human RAD gene promoters have multiple estrogen response elements (EREs), suggesting a robust mechanism of sex steroid hormones in the regulation of RAD gene expression in the uterine artery. In addition, the approach of RNA-seq analysis revealed a downregulation of RAD gene expression in uterine arteries of pregnant ewes acclimatized to high altitude hypoxia.
Of importance, we demonstrated that chronic hypoxia during gestation abrogated pregnancy-induced upregulation of RAD protein expression and increased CAV1.2 channel currents in ovine uterine arteries. These exciting findings and many highly novel leads provide a strong scientific premise for us to move the field forward significantly by launching a new focus of research aimed at understanding the molecular and epigenetic mechanisms of RAD in regulating CAV1.2 channel currents and phenotypic programming of uterine vascular adaptation to pregnancy and gestational hypoxia.
The proposed study will be conducted in a unique animal model of pregnant sheep exposed to high altitude (3801 m/12,470 ft) hypoxia during gestation. The overall hypothesis of the proposed study is that RAD is a novel regulatory mechanism and plays an essential role in the regulation of L-type CAV1.2 calcium channel currents and uterine vascular adaptation to pregnancy and gestational hypoxia.
The proposed study has the strong scientific premise with a novel conceptual framework and mechanistic approach. It will provide new insights into fundamental mechanisms in uterine vascular adaptation to pregnancy and will have a major impact on our understanding of pathophysiologic mechanisms underlying pregnancy complications including preeclampsia caused by gestational hypoxia.
Of importance, the similarity in uterine artery hemodynamics and maternal blood pressure responses to gestational hypoxia between pregnant ewes and pregnant women, as well as likely common mechanisms of RAD gene regulation by sex steroid hormones, will provide much-needed translational relevance of the proposed study in the understanding of maternal cardiovascular complications in response to hypoxia during pregnancy.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Loma Linda,
California
923500225
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 297% from $807,492 to $3,205,068.
Loma Linda University was awarded
Uterine Artery Hemodynamics in Pregnancy Gestational Hypoxia: RAD Mechanisms
Project Grant R01HL169157
worth $3,205,068
from National Heart Lung and Blood Institute in June 2023 with work to be completed primarily in Loma Linda California United States.
The grant
has a duration of 3 years 10 months and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 5/21/26
Period of Performance
6/1/23
Start Date
4/30/27
End Date
Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to R01HL169157
Additional Detail
Award ID FAIN
R01HL169157
SAI Number
R01HL169157-2252288134
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
SZAKFNU35ZX5
Awardee CAGE
1K7Y1
Performance District
CA-23
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) | Health research and training | Grants, subsidies, and contributions (41.0) | $807,492 | 100% |
Modified: 5/21/26